Great Point Partners as of March 31, 2020
Portfolio Holdings for Great Point Partners
Great Point Partners holds 32 positions in its portfolio as reported in the March 2020 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| ACADIA Pharmaceuticals (ACAD) | 8.8 | $84M | 2.0M | 42.25 | |
| Zymeworks | 8.6 | $83M | 2.3M | 35.47 | |
| Ptc Therapeutics I (PTCT) | 8.2 | $79M | 1.8M | 44.61 | |
| Iovance Biotherapeutics (IOVA) | 7.5 | $72M | 2.4M | 29.93 | |
| Constellation Pharmceticls I | 6.5 | $62M | 2.0M | 31.43 | |
| Biohaven Pharmaceutical Holding | 5.6 | $54M | 1.6M | 34.03 | |
| United Therapeutics Corporation (UTHR) | 5.5 | $53M | 556k | 94.83 | |
| Sage Therapeutics (SAGE) | 5.5 | $52M | 1.8M | 28.72 | |
| Nextcure (NXTC) | 5.1 | $49M | 1.3M | 37.07 | |
| Acceleron Pharma | 5.0 | $48M | 536k | 89.87 | |
| Myokardia | 4.2 | $41M | 864k | 46.88 | |
| Gw Pharmaceuticals Plc ads | 4.1 | $39M | 450k | 87.57 | |
| Tg Therapeutics (TGTX) | 3.7 | $35M | 3.6M | 9.84 | |
| Abiomed | 3.3 | $31M | 216k | 145.16 | |
| Momenta Pharmaceuticals | 2.8 | $27M | 979k | 27.20 | |
| Prothena (PRTA) | 2.3 | $22M | 2.1M | 10.70 | |
| Arena Pharmaceuticals | 1.7 | $16M | 388k | 42.00 | |
| Abeona Therapeutics | 1.6 | $15M | 7.2M | 2.10 | |
| Chemocentryx | 1.5 | $14M | 357k | 40.18 | |
| Axonics Modulation Technolog (AXNX) | 1.4 | $14M | 543k | 25.41 | |
| Molecular Templates | 1.1 | $11M | 825k | 13.29 | |
| Millendo Therapeutics | 1.0 | $9.1M | 1.7M | 5.28 | |
| Arvinas Ord (ARVN) | 0.9 | $8.9M | 222k | 40.30 | |
| Cytokinetics (CYTK) | 0.8 | $7.8M | 664k | 11.79 | |
| Viewray (VRAYQ) | 0.7 | $6.9M | 2.8M | 2.50 | |
| Liquidia Technologies (LQDA) | 0.6 | $6.0M | 1.3M | 4.71 | |
| Axsome Therapeutics (AXSM) | 0.6 | $5.9M | 100k | 58.83 | |
| Menlo Therapeutics | 0.5 | $4.4M | 1.7M | 2.68 | |
| Sangamo Biosciences (SGMO) | 0.4 | $4.0M | 634k | 6.37 | |
| Kura Oncology (KURA) | 0.2 | $1.8M | 180k | 9.95 | |
| Cytomx Therapeutics (CTMX) | 0.1 | $1.1M | 140k | 7.67 | |
| Neoleukin Therapeutics | 0.0 | $459k | 40k | 11.38 |
